Viveve Medical (VIVE) Financials

$0.00

$0.00 (-86.67%)

As on 16-Sep-2026 16:00EDT

Market cap

$0 Mln

Revenue (TTM)

$7 Mln

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	--	6.43	5.48	6.57	18.52	15.29
Cost of Revenue	--	5.81	5.18	5.55	11.20	7.84
Gross Profit	--	0.62	0.30	1.02	7.32	7.44
Operating Expenses	--	22.17	18.79	30.95	52.29	41.17
Operating Profit (EBIT)	--	-21.55	-18.50	-29.94	-44.97	-33.73
Other Income	--	--	-2.51	-7.49	--	-0.06
Profit before Tax	--	-21.77	-21.53	-41.90	-49.32	-36.96
Provision for Tax	--	0.26	0.38	4.82	-0.14	-0.33
Profit after Tax (Net Income)	--	-22.03	-21.92	-42.53	-49.18	-36.63
Minority Interest	--	-0.26	-0.38	-0.63	-0.66	--
Consolidated Profit	--	-26.72	-26.06	-42.91	-49.98	-36.96

Liabilities ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	--	15.07	6.97	16.52	4.91	-2.60
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	6.31	5.44	4.15	31.16	29.28
Current Liabilities	--	4.53	4.22	6.31	10.76	9.40
Total Liabilities	--	25.91	16.63	26.98	46.83	36.08

Assets ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	--	3.68	3.79	4.79	4.93	4.01
Current Assets	--	22.24	12.84	22.19	41.90	32.07
Total Assets	--	25.91	16.63	26.98	46.83	36.08
Total Debt*	--	5.35	5.99	4.25	30.53	28.95
Net Current Assets	--	17.71	8.63	15.88	31.14	22.67

Cashflow ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	--	-12.88	-15.23	-31.24	-43.09	-34.85
Cash Flow from Investing Activities	--	-0.46	-0.78	-1.09	-2.14	-3.41
Cash from Financing Activities	--	25.97	9.23	16.11	54.03	50.90
Net Cash Inflow / Outflow	--	--	-6.79	-16.22	8.79	12.64

Financials Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	--	-2.18	-10.10	-60.10	-1,385.41	-1,888.14
Cash EPS ($)	--	-2.07	-9.50	-58.43	-1,363.27	-1,865.00
Adjusted Book Value ($)	--	1.49	3.21	23.35	138.37	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.28	-7.02	-44.14	-1,213.80	-1,796.55
Free Cash Flow per Share ($)	--	-1.32	-7.38	-45.68	-1,274.14	-1,843.20

Profitability Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	--	-131.97	-129.91	-151.31	-159.20	-205.95
ROE (%)	--	-199.88	-186.55	-396.83	-4,254.50	2,437.94
ROA (%)	--	-103.55	-100.51	-115.23	-118.64	-144.70
EBIT Margin (%)	--	-323.23	-376.38	-485.17	-242.83	-221.02
Net Margin (%)	--	-342.78	-738.13	4,592.44	-265.60	-240.54
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	--	0.17	-0.17	-0.65	0.21	1.14
EBIT Growth (%)	--	-0.72	35.28	29.14	-33.07	-80.66
Net Profit Growth (%)	--	-0.51	48.47	13.53	-34.27	-82.14
EPS Growth (%)	--	0.78	0.83	0.96	0.27	0.00
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	--	-0.52	-0.47	-0.02	0.00	0.00
Price / Book Value	--	0.76	1.46	0.05	0.01	-0.04
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	--	0.12	-0.46	0.27	-0.02	-0.25
Close Price ($)	0.43	1.14	4.70	12.60	1,050.00	4,970.00
High Price ($)	1.30	5.40	20.90	1,340.00	5,223.00	11,160.00
Low Price ($)	0.35	1.07	4.14	7.90	1,000.00	3,750.00
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	--	0.36	0.86	0.26	6.21	-11.13
Short term debt to equity ratio	--	0.01	0.15	0.02	--	--
Current Ratio	--	4.91	3.05	3.52	3.89	3.41
Quick Ratio	--	4.58	2.27	2.75	3.51	3.16
Interest Coverage	--	-20.77	-22.66	-7.32	-10.28	-10.66

Operating Efficiency Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	--	8.54	14.05	23.95	30.80	40.64
Asset Turnover	--	0.30	0.25	0.18	0.45	0.60
Receivable days	--	37.49	78.10	202.37	117.53	99.20
Inventory Days	--	148.65	285.94	295.44	106.16	118.20
Payable days	--	74.26	87.70	184.30	143.42	183.58
Cash Conversion Cycle	--	111.88	276.33	313.50	80.28	33.82